Detalhe da pesquisa
1.
Clinical Utility of Circulating Tumor DNA in Patients With Advanced KRASG12C-Mutated NSCLC Treated With Sotorasib.
J Thorac Oncol
; 2024 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38615940
2.
Hepatotoxicity in patients with non-small cell lung cancer treated with sotorasib after prior immunotherapy: a comprehensive clinical and pharmacokinetic analysis.
EBioMedicine
; 102: 105074, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38507877
3.
Tobacco Smoking-Related Mutational Signatures in Classifying Smoking-Associated and Nonsmoking-Associated NSCLC.
J Thorac Oncol
; 18(4): 487-498, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36528243
4.
Prevalence, clinical and molecular characteristics of early stage EGFR-mutated lung cancer in a real-life West-European cohort: Implications for adjuvant therapy.
Eur J Cancer
; 181: 53-61, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36638752
5.
Chemotherapy for patients with EGFR-mutated NSCLC after progression on EGFR-TKI's: Exploration of efficacy of unselected treatment in a multicenter cohort study.
Lung Cancer
; 181: 107248, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37216839
6.
Exploring the use of circulating tumor DNA for mutational signature analysis.
Lung Cancer
; 193: 107844, 2024 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38833851
7.
Lung Cancer in Brunei Darussalam.
J Thorac Oncol
; 19(5): 698-705, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38719425
8.
Efficacy and Tolerability of Osimertinib and Sotorasib Combination Treatment for Osimertinib Resistance Caused by KRAS G12C Mutation: A Report of Two Cases.
JCO Precis Oncol
; 7: e2300451, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-38096473